Penserra Capital Management LLC Makes New $2.25 Million Investment in Oscar Health, Inc. (NYSE:OSCR)

Penserra Capital Management LLC purchased a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 106,193 shares of the company's stock, valued at approximately $2,252,000.

A number of other large investors also recently modified their holdings of OSCR. Wealth Enhancement Advisory Services LLC boosted its position in shares of Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock worth $255,000 after purchasing an additional 844 shares in the last quarter. American International Group Inc. lifted its position in shares of Oscar Health by 1.3% during the 1st quarter. American International Group Inc. now owns 79,411 shares of the company's stock worth $1,181,000 after buying an additional 1,009 shares in the last quarter. Summit Trail Advisors LLC increased its stake in shares of Oscar Health by 5.4% during the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company's stock worth $329,000 after purchasing an additional 1,065 shares during the last quarter. KBC Group NV increased its stake in shares of Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after purchasing an additional 1,328 shares during the last quarter. Finally, Arizona State Retirement System increased its stake in shares of Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company's stock worth $602,000 after purchasing an additional 1,351 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Trading Down 3.4 %

Shares of OSCR stock traded down $0.57 during mid-day trading on Tuesday, reaching $16.28. The stock had a trading volume of 2,623,633 shares, compared to its average volume of 3,423,393. The stock's 50-day moving average price is $17.80 and its two-hundred day moving average price is $18.15. Oscar Health, Inc. has a 52-week low of $7.29 and a 52-week high of $23.79. The firm has a market capitalization of $4.03 billion, a PE ratio of -280.95 and a beta of 1.67. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm had revenue of $2.42 billion during the quarter, compared to analysts' expectations of $2.33 billion. During the same quarter in the previous year, the firm posted ($0.29) EPS. Oscar Health's revenue was up 68.3% compared to the same quarter last year. Equities analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In other news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares in the company, valued at approximately $1,384,906.18. This trade represents a 3.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Alessandrea C. Quane sold 16,793 shares of the business's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the sale, the executive vice president now directly owns 392,607 shares in the company, valued at approximately $6,697,875.42. This represents a 4.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 194,569 shares worth $3,433,319. 25.11% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

OSCR has been the subject of a number of recent research reports. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 price objective for the company. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Oscar Health currently has an average rating of "Moderate Buy" and an average target price of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.